Revenue
2017
2018
2019
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $17,775 | $16,310 | $4,500 |
| Gross profit | — | — | — | — | — | — | $4,360 | $4,665 | $1,255 |
| Operating expenses | $489,951 | $490,437 | $471,953 | $485,514 | $501,955 | $158.4M | $50,898 | — | — |
| Operating income | — | — | — | — | — | — | −$46,538 | −$66,740 | −$31,261 |
| Net income | −$1.3M | −$490,437 | −$471,953 | −$485,514 | −$501,955 | −$158.4M | −$46,538 | −$67,738 | −$31,261 |
| Basic EPSper diluted share | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |